Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations
14 March 2024 - 12:00AM
Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF)
(“
Sirona” or the “
Company”)
announces a significant achievement in its quest to transform the
skincare industry. Its subsidiary, TFChem, has successfully
received formulations for its eagerly awaited
GlycoProteMim™ based anti-aging serum from its formulation
partner, Global Beauty Consulting (GBC). This marks a crucial step
in Sirona Biochem's plan to offer innovative skincare solutions.
The chosen formulation will not only define the
brand but also lay the foundation for a broader range of products.
The team is in the process of selecting the precise formulation
that will undergo standard safety evaluations and be used in the
upcoming clinical trial. This is in preparation for the planned
product launch in early 2025, ensuring compliance with regulatory
standards in the European, US, and Canadian markets.
‘We are thrilled to unveil these innovative
formulations for our GlycoProteMim based anti-aging serum. Our
mission at Sirona Biochem is to revolutionize skincare through
science and these formulations represent a significant step towards
achieving that goal.” reports Sirona’s Chief Scientific Officer Dr
Geraldine Deliencourt-Godfrey. In line with our commitment to
transparency and innovation, samples of the GlycoProteMim-based
anti-aging serum formulations will be distributed to prospective
key stakeholders in Asia, Europe, and North America.
About Sirona Biochem Corp.
Sirona is a cosmetic ingredient and drug
discovery company with a proprietary platform technology. Sirona
specializes in stabilizing carbohydrate molecules with the goal of
improving efficacy and safety. New compounds are patented for
maximum revenue potential.
Sirona’s compounds are licensed to leading
companies around the world in return for licensing fees, milestone
fees and ongoing royalty payments. Sirona’s laboratory, TFChem, is
in France and is the recipient of multiple French national
scientific awards and European Union and French government grants.
For more information, please visit www.sironabiochem.com.
For more information regarding this press
release, please contact:
Investor Enquiries:
Christopher HoptonChief Financial Officer
Phone: (604) 641-4466Email: info@sironabioche.com
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Forward Looking Statements
This news release includes certain statements
that may be deemed “forward-looking statements”. All statements in
this new release, other than statements of historical facts, that
address events or developments that the Company expects to occur,
are forward-looking statements. Forward-looking statements are
statements that are not historical facts and are generally, but not
always, identified by the words “expects”, “plans”, “anticipates”,
“believes”, “intends”, “estimates”, “projects”, “potential” and
similar expressions, or that events or conditions “will”, “would”,
“may”, “could” or “should” occur. Although the Company believes the
expectations expressed in such forward-looking statements are based
on reasonable assumptions, such statements are not guarantees of
future performance and actual results may differ materially from
those in the forward-looking statements. Factors that could cause
the actual results to differ materially from those in
forward-looking statements include market prices, continued
availability of capital and financing, and general economic, market
or business conditions. Investors are cautioned that any such
statements are not guarantees of future performance and actual
results or developments may differ materially from those projected
in the forward-looking statements. Forward-looking statements are
based on the beliefs, estimates and opinions of the Company’s
management on the date the statements are made. Except as required
by applicable securities laws, the Company undertakes no obligation
to update these forward-looking statements in the event that
management's beliefs, estimates or opinions, or other factors,
should change.
Sirona Biochem (TG:ZSB)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sirona Biochem (TG:ZSB)
Historical Stock Chart
From Oct 2023 to Oct 2024